title: Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
abstract: In vitro activity of caspofungin and voriconazole against 184 clinical isolates of Candida and other medically important yeasts in comparison with that of fluconazole, ketoconazole, itraconazole and amphotericin B was determined by using a disk diffusion method (Neo-Sensitabs) standardized according to the recommendations of the CLSI documents M44-A and M44-S1 (same medium: Mueller-Hinton plus methylene blue; inoculum and minimal inhibitory concentration/zone breakpoints). Seventy-two percent of clinical isolates were susceptible to caspofungin, 23.6% showed an intermediate susceptibility (most of them were Candida parapsilosis) and 4.3% were resistant (values for Candida spp. were 71.2, 23.8 and 5%, respectively). For voriconazole, 96.7% of clinical isolates were susceptible and 3.3% were resistant (Candida spp.: 96 and 3.8%, respectively). Both caspofungin and voriconazole showed high activity against a wide variety of clinically important yeasts.
authors: Departamento de Microbiología, ACIA, Barcelona, Spain. acarrillo@ya.com
authors: A J
authors: AJ
authors: Carrillo-Muñoz
authors: G
authors: G
authors: Quindós
authors: O
authors: O
authors: del Valle
authors: P
authors: P
authors: Santos
authors: G
authors: G
authors: Giusiano
authors: P A
authors: PA
authors: Ezkurra
authors: M D
authors: MD
authors: Estivill
authors: J B
authors: JB
authors: Casals
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects*; D000077336:Caspofungin; D003454:Cryptococcus / Q000187:drug effects; D052978:Disk Diffusion Antimicrobial Tests; D025141:Drug Resistance, Fungal; D054714:Echinocandins / Q000494:pharmacology*; D015725:Fluconazole / Q000494:pharmacology; D017964:Itraconazole / Q000494:pharmacology; D007654:Ketoconazole / Q000494:pharmacology; D055666:Lipopeptides; D011743:Pyrimidines / Q000494:pharmacology*; D012248:Rhodotorula / Q000187:drug effects; D014230:Triazoles / Q000494:pharmacology*; D014250:Trichosporon / Q000187:drug effects; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D011743:Pyrimidines; D014230:Triazoles; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D000077336:Caspofungin; D065819:Voriconazole; D007654:Ketoconazole